Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet S Sunness

Showing results (61-70 of 65) with videos related to

Pageof 7
Sort By:
You have reached the last page of results.This site can display upto 65 results.
Ophthalmic Research|July 14, 2024
The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18)Rupert Wolfgang Strauss, Lang Lang, Alexander Ho, et al.
JAMA Ophthalmology|August 2, 2019
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11Rupert W Strauss, Xiangrong Kong, Alexander Ho, et al.
Ophthalmic Research|June 26, 2018
Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1)Rupert W Strauss, Xiangrong Kong, Millena G Bittencourt, et al.
The British Journal of Ophthalmology|June 22, 2018
Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8Kaoru Fujinami, Rupert W Strauss, John Pei-Wen Chiang, et al.
The New England Journal of Medicine|August 30, 2008
Toll-like receptor 3 and geographic atrophy in age-related macular degenerationZhenglin Yang, Charity Stratton, Peter J Francis, et al.
Pageof 7

Showing results (61-70 of 65) with videos related to

Sort By:
Pageof 7
You have reached the last page of results.This site can display upto 65 results.
Ophthalmic Research|July 14, 2024
The Progression of Stargardt Disease as Determined by Spectral-Domain Optical Coherence Tomography over a 24-Month Period (ProgStar Report No. 18)Rupert Wolfgang Strauss, Lang Lang, Alexander Ho, et al.
JAMA Ophthalmology|August 2, 2019
Progression of Stargardt Disease as Determined by Fundus Autofluorescence Over a 12-Month Period: ProgStar Report No. 11Rupert W Strauss, Xiangrong Kong, Alexander Ho, et al.
Ophthalmic Research|June 26, 2018
Scotopic Microperimetric Assessment of Rod Function in Stargardt Disease (SMART) Study: Design and Baseline Characteristics (Report No. 1)Rupert W Strauss, Xiangrong Kong, Millena G Bittencourt, et al.
The British Journal of Ophthalmology|June 22, 2018
Detailed genetic characteristics of an international large cohort of patients with Stargardt disease: ProgStar study report 8Kaoru Fujinami, Rupert W Strauss, John Pei-Wen Chiang, et al.
The New England Journal of Medicine|August 30, 2008
Toll-like receptor 3 and geographic atrophy in age-related macular degenerationZhenglin Yang, Charity Stratton, Peter J Francis, et al.
Pageof 7